A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors
Clinical trial NCT04613492 · TERMINATED
Trial details
- NCT number
- NCT04613492
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2024-05-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.